ResMed | RMD - 债务利息支出

金融业

USD 239.53

USD 8.21B

现金及等价物

USD 1.01B

USD 612.93M

USD 3.51B

USD 1.32B

USD 825.92M

股息收益率

0.28

USD 454.34M

USD 533.74M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 5.95B

USD 870.57M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 35.44B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

19.85

USD 474.16M

USD 1.46B

销售和管理费用

USD 290.66M

USD 1.02B

贸易债权人

USD 320.68M

应收帐款人

USD 1.04B

	债务利息支出	更改		日
Ansell	USD 20.6M		300K	2025-12
Artivion	USD 5.53M		589K	2025-12
AtriCure	USD 1.2M		15K	2026-06
Baxter International	USD 64M		14M	2026-06
Cochlear	AUD 6.3M		3.65M	2025-12
Cooper Companies	USD 21.5M		600K	2026-06
CSL	USD 215M		111M	2025-12
Dexcom	USD 3.1M		100K	2026-09
Edwards Lifesciences	USD 30M		5.9M	2026-06
Fisher Paykel Healthcare	NZD 4.8M		700K	2026-06
Globus Medical	USD 5.53B		39.93M	2026-09
Haemonetics	USD 5.08M		2.32M	2026-03
Idexx Laboratories	USD 7.46M		2.72M	2026-09
Inogen	1.03M		384K	2025-03
Insulet	USD 12.3M		1.3M	2026-09
Integra LifeSciences	USD 22.96M		33K	2026-09
Intuitive Surgical	USD 19.35B		1.53B	2026-09
Medtronic	USD 186M		10M	2026-06
Philips	EUR 84M		1000K	2026-09
Ramsay Health Care	AUD 300.6M		15.5M	2025-12
ResMed	USD 8.79M		14.55M	2025-09
Sigma Healthcare	AUD 7.97M		365K	2024-01
Sonic Healthcare	AUD 86.91M		43.94M	2024-12
Steris	USD 11.2M		4.6M	2026-09
Teleflex	USD 21.21M		6.75M	2026-09
Thermo Fisher Scientific	USD 417M		63M	2026-09